Catalyst Awardees

On this page

Learn more about the Catalyst Award for the Development of Diagnostics, Devices, Therapeutics and Digital Health

Fall 2012

  • Adam Abate PhD Detection and molecular profiling of cancer cells with Megadroplet Arrays
  • Nancy Boudreau PhD Topical HoxA5 gene therapy for Squamous Cell Carcinoma
  • Jonah Chan PhD A Binary Indicant of Myelination using Micropillar Arrays: A high-throughput screening platform for identifying remyelination therapeutics for Multiple Sclerosis
  • Michael Conte MD Pro-Resolving Vascular Devices
  • Brian Feeley MD Affordable 3-Dimensional Motion Analysis to Evaluate Lower Extremity Injury Risk
  • John Gross PhD Inhibition of HIV infectivity by targeting the Ubiquitin Proteasome System
  • Michael Harrison MD Amnioseal: Preventing premature birth in fetal intervention
  • Roberta Keller MD Antenatal sildenafil to prevent neonatal pulmonary hypertension in severe fetal diaphragmatic hernia
  • Ngoc Ly MPH, MD Promoting Asthma Self-Management through an Interactive AsthmaMD Mobile App
  • Mary Nakamura MD A Recombinant Fusion Protein that redirects VEGF to actively kill cancer cells: R1FasL
  • Yong Pang PhD Quantitative Assessment of Liver Fat using Fast MR Imaging and 8-Channel Microstrip Coil Array
  • Catherine Park MD Development of a Real-Time Intraoperative Fluorescent Imager for Microscopic Residual Tumor
  • Anand Patel MD Intravenous Chemotherapy Filter: A Novel Device for High Dose Chemotherapy Delivery During Transarterial Chemoembolization
  • Jayant Rajan MD Estimation of the prevalence of chronic disease in an urban slum population in Brazil using a mobile computing platform
  • Shuvo Roy PhD Enabling the Feasibility Demonstration of a Bioartificial Pancreas
  • Marshall Stoller MD A Novel Device to Promote Ambulation of the Hospitalized Patient
  • Naomi Stotland MD Pregnancy Weight Gain Coach—A Smartphone App
  • Leslee Subak MD Novel mHealth app and embedded platforms (wearable devices) for urinary incontinence treatment and research
  • Francis Szoka PhD Oral and Pulmonary Delivery of Proteins
  • Lili Zhou PhD Novel strategies to predict and enhance the activity of natural killer cells against Multiple Myeloma

Back to top

Spring 2012

  • Conor Caffrey PhD Developing a new chemotherapeutic for treatment of the neglected tropical disease, schistosomiasis
  • John Chorba MD Targeting the serine protease PCSK9 via covalent complementarity
  • Charles Craik PhD Validation of KSHV protease as a therapeutic target through allosteric inhibition
  • Tejal Desai PhD Nanoengineered thin film devices for ocular drug delivery
  • John Fahy MD Modified carbohydrate derivatives as novel reducing agents for the treatment of pathologic mucus in acute and chronic airway disease.
  • Ari Green MD Retinal imaging of amyloid-beta as a screening tool for glaucoma and Alzheimer's disease.
  • Wolfgang Korn MD Development of a predictive marker for sensitivity to treatment with MEK and EGFR
  • Peder Larson PhD Simultaneous Perfusion and metabolic imaging in a prostate cancer
  • Robin Shaw MD, PhD A novel biomarker for heart failure based on cardiomyocyte biology
  • Jay Stewart MD A novel photodynamic therapy for the treatment of infectious keratitis
  • Ashley Ward MD Targeting hyperactive Ras with kinase inhibitors in juvenile myelomonocytic

Back to top

Fall 2011

  • Adam Abate PhD Robust detection and genotyping of rare circulating tumor cells in human blood
  • Christopher Barnett MD, MPH Evaluation of the acute hemodynamic effects of dark chocolate in patients with WHO Group I pulmonary arterial hypertension
  • Aditi Bhargava PhD Targeted delivery of RNAi molecules for treatment of neuronal pathophysiologies
  • Hobart Harris MD Prevention of incisional hernias
  • Michael Matthay MD Allogeneic human mesenchymal stem cells for the treatment of human acute lung injury
  • Synthia Mellon PhD Neurosteroids as therapeutics for brain disorders
  • Robert Messing MD Discovery of a PKC epsilon-selective inhibitor to treat pain
  • Mary Nakamura MD Recombinant fusion proteins that redirect VEGF to actively kill cancer cells: R1FasL and R1TRAIL
  • Douglas Nixon MD, PhD Herv antibodies and breast cancer
  • Mark Wilson MD Catheter-directed tissue ablation in the interventional MRI environment
  • Yvonne Wu MD, MPH Neonatal erythropoietin in asphyxiated term infants
  • Iwei Yeh MD, PhD Droplet digital PCR detection of circulating melanoma DNA—detecting early metastasis and progression in the age of targeted therapy

Back to top

Spring 2011

  • Adam Gazzaley MD, PhD Development of integrated physical and cognitive therapeutic software
  • Lily Jan PhD Novel blockers of TMEM16A-CaCC calcium-activated chloride channels for asthma treatment
  • Jay Nadel MD Use of EGFR inhibitors in the treatment of respiratory viral infections including virus-induced asthma exacerbations
  • Douglas Nixon MD, PhD A monoclonal antibody to cure HIV-1 infection
  • Michael Page PhD In vivo diagnostics for cardiovascular disease
  • Paul Simpson MD Treatment of cardiomyopathy and heart failure
  • Louise Swainson PhD The use of synthetic peptidoglycan-peptide conjugates for the induction of antigen-specific tolerance in autoimmune disease

Back to top

Fall 2010

  • Anthony Luke MD Validation of the RunSafe: 2-Dimensional gait analysis method with gold standard 3-Dimensional biomechanical analysis
  • Daniel Schwartz MD Use of phase contrast OCT for imaging the human retinal vasculature
  • Qizhi Tang PhD Manufacturing donor-specific regulatory T cells

Back to top

Spring 2010

Back to top

Accelerate is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

Cite CTSI NIH Funding Acknowledgment: Important — All publications resulting from the utilization of CTSI resources are required to credit the CTSI grant by including the NIH Funding Acknowledgment and must comply with NIH Public Access Policy.